Emerald Featured in Business News
November 21, 2019
- Emerald Clinics has found value in building clinical evidence
Thursday, 24 October 2019 – Public attitudes towards medical use of cannabis may have shifted in
recent years, but Emerald Clinics chief executive Michael Winlo says the industry still suffers from a maturity problem.
Dr Winlo spent more than three years overseeing development of novel therapies as chief executive of Linear Clinical Research before joining Emerald Clinics this past August. Emerald was founded in 2018 and operates as a clinical researcher of cannabinoid medicines, with facilities in Perth, Melbourne and Sydney.
Mr Winlo said the industryʼs lack of reliable clinical research was contributing to broader confusion over its effectiveness in a medical setting.
That dearth of reliable research was the key reason Dr Winlo joined